Paul Eggleton

6PUBLICATIONS
4CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Biologically active moleculesInnate immunityCancer therapy (excl. chemotherapy and radiation therapy)Autoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 14, 2024
Endothelial Cell-Derived Soluble CD200 Determines the Ability of Immune Cells to Cross the Blood-Brain Barrier.

Myriam Pujol, Tautvydas Paskevicius, Alison Robinson

|May 27, 2023
STING-Triggered CNS Inflammation in Human Neurodegenerative Diseases.

Alex S Ferecskó, Miranda J Smallwood, Adrian Moore

|Jan 18, 2023
The therapeutic mavericks: Potent immunomodulating chaperones capable of treating human diseases.

Paul Eggleton, Jorge De Alba, Michael Weinreich

|Nov 20, 2021
Endoplasmic reticulum stress-induced release and binding of calreticulin from human ovarian cancer cells.

Trefa M Abdullah, Jacqueline Whatmore, Edwin Bremer

|Aug 22, 2019
Galectin-9 Is a Possible Promoter of Immunopathology in Rheumatoid Arthritis by Activation of Peptidyl Arginine Deiminase 4 (PAD-4) in Granulocytes.

Valerie R Wiersma, Alex Clarke, Simon D Pouwels

Pageof 1